Mia's Feed
Medical News & Research

Osteoarthritis Management: Bridging the Gap Between Evidence-Based Guidelines and Real-World Practices

Osteoarthritis Management: Bridging the Gap Between Evidence-Based Guidelines and Real-World Practices

Share this article

Recent research highlights a significant gap between osteoarthritis treatment guidelines and real-world practices, emphasizing the need for better adherence to evidence-based interventions like weight management and patient education.

2 min read

Osteoarthritis is a common and debilitating condition that causes chronic joint pain, often impacting daily life and overall quality of life. The European Alliance of Associations for Rheumatology (EULAR) has developed comprehensive clinical guidelines for managing osteoarthritis, especially focusing on the hand, hip, and knee joints. These guidelines emphasize the importance of evidence-based interventions such as patient education, weight management, physical therapy, and appropriate medication use.

Despite clear recommendations, realities in clinical practice often diverge from these guidelines. Recent data presented at the 2025 EULAR Congress from the Austrian BLOAR registry shed light on this discrepancy. The registry, which analyzed the healthcare usage patterns of 1,716 patients with osteoarthritis, revealed that most patients are being treated mainly for knee osteoarthritis—over half of the cases—with significant proportions also suffering from hand and hip osteoarthritis.

The findings indicate that over 80% of patients suffer from moderate to severe disease, with many experiencing substantial pain during activity. Notably, while a high percentage of patients received consultations and physical therapy—either active (functional therapy) or passive modalities—the implementation of weight management strategies remains drastically low, with only about 10% receiving dietary or weight-loss support, despite strong guidelines advocating for such interventions.

Additionally, many patients resort to supplements like vitamins and plant-based products, which are not recommended by evidence-based guidelines. This reliance on non-evidence-based treatments highlights a significant gap in the application of proven therapies.

Valentina Schmolik and colleagues emphasize the need for increased awareness among healthcare providers regarding the importance of evidence-based management of osteoarthritis. Bridging the gap between guidelines and practice can lead to better patient outcomes. Efforts should focus on educating both clinicians and patients about effective strategies, including weight control and proper medication use, while addressing misconceptions that lead to the popularity of unproven treatments.

Improving adherence to clinical guidelines is essential for optimizing care and reducing unnecessary, non-evidence-based practices. Such alignment can significantly enhance the quality of life for individuals suffering from osteoarthritis and ensure healthcare resources are utilized effectively.

Source: https://medicalxpress.com/news/2025-06-osteoarthritis-evidence-based-therapies.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Rise in Salmonella Infections in England: How to Protect Yourself

Salmonella cases in England have hit a ten-year peak, prompting health experts to advise proper food hygiene practices to stay safe. Learn how to protect yourself against infection.

Excess Body Fat and Liver Cancer Immunotherapy Resistance: The Role of Diet in Improved Outcomes

Recent studies reveal that excess body fat within liver tumors can hinder immunotherapy effectiveness. Research suggests that healthier diets and lifestyle choices may improve treatment responses in liver cancer patients resistant to current therapies.

Promising Results for HER3-Targeted Antibody-Drug Conjugate in Treatment-Resistant Solid Tumors

Early clinical trial results show that the HER3-targeted antibody-drug conjugate DB-1310 offers hope for patients with resistant advanced solid tumors, including EGFR-mutant non-small cell lung cancer, by extending survival and maintaining manageable side effects.

Understanding Sex Differences in Neurological Disorders

Recent research highlights how sex influences dopamine regulation in the brain, opening new avenues for personalized treatments of neurological and psychiatric conditions such as TS, schizophrenia, and ADHD.